FOXG1
protein-codingforkhead box G1, the group of Forkhead boxes
Gene summary
This locus encodes a member of the fork-head transcription factor family. The encoded protein, which functions as a transcriptional repressor, is highly expressed in neural tissues during brain development. Mutations at this locus have been associated with Rett syndrome and a diverse spectrum of neurodevelopmental disorders defined as part of the FOXG1 syndrome. This gene is disregulated in many types of cancer and is the target of multiple microRNAs that regulate the proliferation of tumor cells. [provided by RefSeq, Jul 2020]
- FKHL2
- FOXG1B
- FKHL4
- FKH2
- FKHL1
- FOXG1C
- FKHL3
- FOXG1A
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~5.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0100040
Submitter: ClinGen
Haploinsufficiency of the FOXG1 gene causes FOXG1 disorder, a condition sometimes referred to as the congenital variant of Rett syndrome. FOXG1 disorder, however, is a clinically distinct entity characterized by onset of neurodevelopmental impairment congenitally or during early infancy, in contrast to typical Rett syndrome in which symptoms appear after a period of normal development. Patients with FOXG1 disorder can also have epilepsy, motor dysfunction, stereotypic hand movements, abnormal breathing, lack of speech development, and corpus callosum hypoplasia on MRI. Variants in FOXG1 were first reported in patients with this disorder by Ariani et al. (2008). Males and females are equally affected, and the mechanism of disease is loss of function. Both sequence and copy number loss variants have been reported in patients with FOXG1 disorder. All reported variants are presumed to have arisen de novo. Experimental evidence, including mouse models with neurological phenotypes consistent with FOXG1 disorder (Xuan et al 1995, Shen et al. 2006, Tian et al. 2012) as well as interaction with MECP2, the causative gene of classical Rett syndrome (Dastidar et al 2012, Orlic-Milacic et al 2014) support the role of FOXG1 in this disease. This disease association is not accounted for in this assessment. In summary, the association between FOXG1 and FOXG1 disorder has been classified as definitive. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. Approved by the ClinGen Rett/Angelman Expert Panel 4/30/2018.
Inheritance Pattern: AD
Disease ID:MONDO:0100040
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0013270
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0013270
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0100040
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FOXG1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005249.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 44 | 191 | 22 | 257 | ||
| missense | 32 | 77 | 233 | 61 | 29 | 432 |
| nonsense | 44 | 11 | 55 | |||
| start loss | 1 | 1 | ||||
| frameshift | 91 | 33 | 2 | 126 | ||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 167 | 121 | 280 | 252 | 51 | 871 |
Highest pathogenic variant AF is 0.00000985336
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005240.3 | 1 | MANE Select | |
| Ensembl | ENSP00000339004.3 | 1 | MANE Select | |
| Ensembl | ENSP00000516406.1 | 1 | Standard | |
| Ensembl | ENSP00000794869.1 | 1 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| foxg1a | Danio rerio | Structure: microvillous olfactory receptor neuron Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- FoxO signaling pathway - Homo sapiens (human)
- Tgif disruption of Shh signaling
- Regulation of nuclear SMAD2/3 signaling
Biological Process
- regulation of transcription by RNA polymerase II
- brain development
- aging
- negative regulation of transcription, DNA-templated
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- protein binding
- sequence-specific DNA binding
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000382535
- Coding exons
- 1
- Length
- 3821
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.49 | 84 | 234 | 0.358 | 0.0000115 | 3156 |
| Missense (PolyPhen) | 3 | 62.181 | 0.048246 | 684 | ||
| Synonymous | -2.38 | 137 | 106 | 1.29 | 0.00000569 | 1025 |
| Loss of Function | 2.79 | 0 | 9.09 | 0.00 | 3.97e-7 | 124 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcription repression factor which plays an important role in the establishment of the regional subdivision of the developing brain and in the development of the telencephalon. {ECO:0000269|PubMed:12657635}.;
Recessive Scores
- pRec
- 0.696
Intolerance Scores
- RVIS EVS
- -0.25
- RVIS percentile EVS
- 35.42
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.781
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |